Nitric oxide affects sarcoplasmic calcium release in skeletal myotubes. J Appl Physiol 91: [2117][2118][2119][2120][2121][2122][2123][2124] 2001.-In the present study, we used real-time confocal microscopy to examine the effects of two nitric oxide (NO) donors on acetylcholine (ACh; 10 M)-and caffeine (10 mM)-induced intracellular calcium concentration ([Ca 2ϩ ]i) responses in C2C12 mouse skeletal myotubes. We hypothesized that NO reduces [Ca 2ϩ ]i in activated skeletal myotubes through oxidation of thiols associated with the sarcoplasmic reticulum Ca 2ϩ -release channel. Exposure to diethylamine NONOate (DEA-NO) reversibly increased resting [Ca 2ϩ ]i level and resulted in a dose-dependent reduction in the amplitude of ACh-induced [Ca 2ϩ ]i responses (25 Ϯ 7% reduction with 10 M DEA-NO and 78 Ϯ 14% reduction with 100 M DEA-NO). These effects of DEA-NO were partly reversible after subsequent exposure to dithiothreitol (10 mM). Preexposure to DEA-NO (1, 10, and 50 M) also reduced the amplitude of the caffeineinduced [Ca 2ϩ ]i response. Similar data were obtained by using the chemically distinct NO donor S-nitroso-N-acetylpenicillamine (100 M). These results indicate that NO reduces sarcoplasmic reticulum Ca 2ϩ release in skeletal myotubes, probably by a modification of hyperreactive thiols present on the ryanodine receptor channel. ryanodine receptor; fluorescence; C 2C12 myotubes NITRIC OXIDE (NO) MODULATES in vitro contractility of skeletal muscle (12, 20, 23) . For instance, exposing rat diaphragm muscle strips to the NO donor sodium nitroprusside reduces submaximal force generation (12). However, the specific mechanisms by which NO modifies skeletal muscle contractility are not as yet known. NO synthase (NOS) is the physiological source for NO, and NOS expression has been confirmed in rodent and human skeletal muscle fibers (12, 13, 22) . Generation of NO by skeletal muscles is enhanced by contractile activity (4, 12). The inhibitory effects of NO on force production could result from interference of NO with intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) regulation. One potential target is the sarcoplasmic reticulum (SR). For instance, it has been shown that the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) reduces caffeine-induced Ca 2ϩ release in isolated skeletal muscle SR vesicles (18). However, in intact mouse skeletal muscle fibers, SNAP increased [Ca 2ϩ ] i during submaximal activation without altering force generation (3). These studies (3, 18) are not necessarily conflicting because, in intact cells, [Ca 2ϩ ] i depends on other factors than SR Ca 2ϩ release, such as reuptake and intracellular buffering of Ca 2ϩ , which could be differentially modified by NO.
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In skeletal muscle, Ca 2ϩ is released from the SR via ryanodine receptor (RyR) channels. Hyperreactive thiols present on the RyR channel (15) have been shown to be regulators of the open probability of this channel (18, 26, 28, 30) . Previous studies in skeletal muscle SR vesicles indicated that NO increases the open probability of the RyR channel in the absence of a RyR agonist (26) . However, other studies suggest that NO reduces RyR channel-mediated Ca 2ϩ release in caffeine-activated vesicles (18) . Few studies have been performed on the effects of NO on SR Ca 2ϩ release in intact cells. In a recent study, it was shown that, in mouse single muscle fibers, NO increases [Ca 2ϩ ] i responses during submaximal activation (3). However, it was uncertain whether this was the result of increased RyR channel-mediated Ca 2ϩ release or impaired Ca 2ϩ reuptake.
The purpose of the present study was to investigate the effects of NO on SR Ca 2ϩ release in intact skeletal muscle cells. We measured [Ca 2ϩ ] i responses by using real-time confocal imaging of fluo 3-loaded C 2 C 12 skeletal myotubes, which were activated by acetylcholine (ACh) and the RyR agonist caffeine. Myotubes were exposed to two different NO donors at varying concentrations. To test the possible involvement of sulfhydryl oxidation, myotubes were exposed to the reducing agent 1,4-dithiothreitol (DTT) after exposure to NO donors. We hypothesized that NO reduces [Ca 2ϩ ] i in activated skeletal myotubes through oxidation of thiols associated with the SR RyR Ca 2ϩ release channel.
METHODS

Cell Culture
C2C12 myoblasts (American Type Culture Collection, Manassas, VA) were grown on 25-mm glass coverslips (37°C, 5% CO2) in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS; GIBCO, Grand Island, NY). The medium also contained 100 U/ml penicillin, 100 g/ml streptomycin, and 2.5 g/ml amphotericin B. When cells reached confluence, FBS was substituted by 10% horse serum (GIBCO) to enhance differentiation into myotubes. Experiments were performed 4-6 days after serum replacement and within 10 days. Under our experimental conditions, spontaneous contractions were observed sporadically and were used as an index of myotube differentiation. All sets of experiments were performed on myotubes from at least two different passages.
Intracellular Ca 2ϩ Imaging
Cytoplasmic free Ca 2ϩ levels were determined by fluo 3 fluorescence. Plated myotubes were incubated in 5 M fluo 3-AM (Molecular Probes, Eugene, OR) in Hanks' balanced salt solution (HBSS) at room temperature for 45 min and subsequently washed with HBSS. The coverslip was placed in an open slide chamber (Warner Instruments, Hamden, CT) mounted on a Nikon Diaphot inverted microscope. The chamber was perfused with HBSS at 1-2 ml/min at room temperature.
Details on the techniques for real-time confocal imaging of [Ca 2ϩ ]i have been previously described (24) . Briefly, an Odyssey XL real-time confocal microscope (Noran Instruments, Middleton, WI) with an Ar-Kr laser and mounted on a Nikon Diaphot inverted microscope was used to visualize fluo 3-AM (Molecular Probes)-loaded myotubes. The confocal system was controlled through a Silicon Graphics Indy workstation and manufacturer-supplied software. A Nikon ϫ40/1.3 oilimmersion objective lens was used to visualize the myotubes.
Image size was set at 640 ϫ 480 pixels, and the pixel area was calibrated by using a standard micrometer (0.063 m 2 / pixel). The 488-nm laser line was used to excite fluo 3 for calcium imaging, and emissions were collected using a 515-nm long-pass filter and high-sensitivity photomultiplier tube. On the basis of preliminary studies, laser intensity and photomultiplier gain were set to ensure that pixel intensities were within 25 and 255 gray levels. To minimize bleaching, laser exposure time was kept as short as possible. The Odyssey confocal system is capable of acquiring 480 frames/s. However, we found that an acquisition rate of 30 frames/s was sufficient for measuring amplitudes of [Ca 2ϩ ]i responses. Eight regions of interest (ROIs) of 5 ϫ 5 pixels were defined before each experiment. The amplitude and rise time of each [Ca 2ϩ ]i transient were measured (see Fig. 1 for definitions). Rise time was normalized for differences in amplitude.
Selection of Myotubes
At confluence, the coverslip was typically dense with myotubes and undifferentiated cells. Only large, intact myotubes were used for [Ca 2ϩ ]i measurements. Usually it was possible to visualize two to three myotubes per image field. Usually two to four ROIs were defined within each myotube; however, [Ca 2ϩ ]i measurements from only one of these ROIs (typically the ROI displaying the largest amplitude response) was used to represent each myotube during the remaining experimental protocol. In general, cells from one coverslip were used for only one experimental protocol. Occasionally, myotubes became partially detached from the coverslip during the experiment. Data from these myotubes were omitted from subsequent analysis. [Ca 2ϩ ]i responses. In C 2C12 myotubes, ACh-induced SR Ca 2ϩ release may be mediated via both ryanodine and inositol 1,4,5-trisphosphate (IP3) sensitive stores (7) . To determine the relative contribution of each of these SR release channels, we evaluated ACh-induced [Ca 2ϩ ]i responses in the presence of high concentrations of ryanodine (100 M) to specifically block the RyR channel and in the presence of the membrane permeant IP3 receptor (IP3R) channel blocker Xestospongin D (XeD, 10 M) (5). Stock solutions of XeD (Calbiochem) were kept frozen, and just before use, XeD was thawed and subsequently diluted to 10 M with HBSS. This XeD concentration was chosen because it had been shown to effectively block IP3R without exhibiting significant effects on RyRmediated SR Ca 2ϩ release (5). After measurement of the initial ACh-induced [Ca 2ϩ ]i response, myotubes were washed, then exposed to 100 M ryanodine for 10 min, and subsequently reexposed to ACh. In a second set of experiments, the effect of 10 M XeD was determined in a similar protocol. In a third set of experiments, the effect of ryanodine on caffeine-induced [Ca 2ϩ ]i responses was studied.
NO and Ca 2ϩ Regulation in Myotubes
Effect of DEA-NO on ACh-induced [Ca 2ϩ ]i transients. After measurement of ACh-induced [Ca 2ϩ ]i transients, myotubes were exposed to standard HBSS for 5 min to ensure optimal reloading of internal Ca 2ϩ stores. Subsequently, myotubes were exposed to one concentration of diethylamine NONOate (DEA-NO; 10, 50 or 100 M, Calbiochem) for 10 min before a second ACh stimulation. The intracellular stores were then reloaded, and myotubes were exposed to the reductant DTT before a final ACh stimulation in the continued presence of DTT. ]i transients. Theoretically, the effects of DEA-NO on [Ca 2ϩ ]i responses could be the result of a NO-independent action of this donor. To rule out this possibility, the caffeine experiments were repeated by using the chemically distinct NO donor SNAP (100 M) instead of DEA-NO.
Effect of DEA-NO on caffeine-induced [
Statistics
The effects of NO donors on the amplitude of ACh and caffeine [Ca 2ϩ ]i responses were analyzed with SPSS/PCϩ, version 9.0. (SPSS, Chicago, IL). Results are expressed as means Ϯ SE. To compare independent groups (e.g., ACh responses in time control and ryanodine-treated myotubes), Mann-Whitney's rank sum test was used. For two related events (i.e., ACh response in XeD compared with subsequent exposure to ryanodine), Wilcoxon's test was used. Significance was set at P Ͻ 0.05. The numbers of myotubes are given with the results for each experimental protocol.
RESULTS
General Characteristics
Myotubes exposed to either ACh or caffeine in the absence of extracellular Ca 2ϩ exhibited no diffuse elevation in [Ca 2ϩ ] i but rather focal areas of high responsiveness (Fig. 1) . This heterogeneity has been recognized previously (6, 9) and is thought to be the result of a heterogeneous distribution of SR (9) . In addition, both baseline fluorescence and the absolute height of the amplitude (in gray levels) varied among myotubes because of differences in uptake of fluo 3-AM. Therefore, effects of experimental procedures were determined by measuring relative changes in the amplitude of [ (Fig. 2) . The amplitude of this latter response was 62.5 Ϯ 4.6% of the response in the presence of Ca 2ϩ compared with 98.2 Ϯ 9. ] i responses to ACh but did not affect the rise time of the responses ( Table  2) . A representative trace is shown in Fig. 3A . In myotubes exposed to 10-M DEA-NO, amplitude of the transient (n ϭ 11) was 75 Ϯ 7% of time control (n ϭ 13; ] i transients (64.2 Ϯ 9.0% of initial amplitude; P Ͻ 0.05 compared with time control; n ϭ 10 and n ϭ 12, respectively). Subsequent exposure to DTT partly re- Values are mean percentages of initial baseline fluorescence Ϯ SE. DEA-NO, diethylamine NONOate; DTT, dithiothreitol. * Significantly different from time control (P Ͻ 0.05). versed the effects of SNAP (92.5 Ϯ 12.0% of initial amplitude; P Ͻ 0.05 compared with time controls).
DISCUSSION
The present study demonstrates that DEA-NO decreases the amplitude of ACh-induced [Ca 2ϩ ] i transients in mouse skeletal myotubes. The effects of DEA-NO were partly reversible after exposure to DTT, indicating that thiol modification contributes to these effects. The fact that both DEA-NO and the chemically distinct NO donor SNAP have similar effects on caffeine-induced [Ca 2ϩ ] i transients suggests that the reduction in the height of amplitude of the [Ca 2ϩ ] i transients result from thiol modification of the RyR Ca 2ϩ -release channel.
Cultured Myotubes
C 2 C 12 mouse skeletal myotubes were used to study the effects of NO on SR Ca 2ϩ release. A potential issue with such a preparation is whether these findings are also applicable to mature skeletal muscles. C 2 C 12 myotubes reach a considerable degree of differentiation as indicated by the expression of fast-twitch skeletal muscle troponin T, ␣-actin, and tropomyosin (16) . Permeabilized myotubes generate measurable force when perfused with Ca 2ϩ , and the concentration needed to generate 50% of maximal force was within the range of mature rat skeletal muscle fibers (16) . In the present study, we purposely selected myotubes that were clearly differentiated as indicated by the presence of at least some sarcomere pattern.
Mechanisms pathway is considered to be of limited relevance in mature skeletal muscle (17) . In our culture preparation, we found a significant contribution of IP 3 -sensitive stores in ACh-induced [Ca 2ϩ ] i transients. When myotubes were preexposed to XeD, which is a membrane-permeable noncompetitive IP 3 R blocker (5), amplitudes of transients elicited by ACh were attenuated by ϳ58%. On the other hand, ryanodine reduced the amplitude of ACh-induced [Ca 2ϩ ] i transients by ϳ50%. This indicates that IP 3 and RyR Ca 2ϩ release channels have about equal contribution to ACh-induced elevation in [Ca 2ϩ ] i in skeletal myotubes. As expected, XeD did not affect caffeine-induced Ca 2ϩ transients. To omit contribution of Ca 2ϩ release via IP 3 R, additional experiments were performed with the RyR agonist caffeine.
Fluorescence Signals
Changes in [Ca 2ϩ ] i were monitored by using fluo 3, which is a nonratiometric dye. To obtain an estimate of the actual [Ca 2ϩ ] i , a calibration procedure should be performed that requires permeabilization of the cells. However, because the myotubes in our preparation were quite delicate, such procedures were impractical, a problem that has been recognized by other groups by using C 2 C 12 myotubes as well (6, 10) . Nevertheless, relative changes in the amplitude of fluorescence signals because of experimental procedures (e.g., DEA-NO) provide (semiquantitative) information on the effects of such procedures on [Ca 2ϩ ] i handling. The lack of significant differences in [Ca 2ϩ ] i responses of time controls indicates that the results with DEA-NO cannot be explained by loss of cell viability.
NO donors. Because NO in its pure form is highly reactive and has limited solubility in aqueous buffers, it is difficult to predictably deliver it into biological systems without decomposition. Therefore, NO donors are frequently used to study the (patho)physiological effects of NO on tissue function. However, a perennial question with the use of NO donors is the validity of equating the donor to the production of NO. Numerous chemically distinct NO donors are commercially available. We chose DEA-NO, which belongs to the group of NO-nucleophile adducts. This type of donor, with the general structure [XN(O)NO] Ϫ , spontaneously releases NO (19) . The rate of release is only dependent on pH, temperature, and the structure of the nucleophilic residue (19) . It is easy to control the initiation of the release of NO from DEA-NO by adjusting pH and temperature of the stock solution. To verify that the observed effects were mediated via NO, part of the experiments were repeated using the chemically distinct NO donor SNAP. In addition, previous studies have shown that parent compounds for DEA-NO (up to 300 M) and breakdown products do not affect force generation in smooth muscle (11) .
Mechanisms of NO Action
It has been shown that thiol groups present on the RyR Ca 2ϩ release channel play a role in the regulation of its open probability (1) . NO can react with thiol groups via either S-nitrosylation or by influencing disulphide formation (25) . Therefore, the RyR Ca 2ϩ release channel is a possible target for NO. The present study supports the hypothesis that NO may modulate SR Ca 2ϩ release by modulating thiol groups in intact cells. DEA-NO had dose-dependent effects on AChinduced [Ca 2ϩ ] i responses, and these effects were partly reversible after exposure to the reducing agent DTT. Although ACh in vivo initiates the excitationcontraction coupling cascade, these data do not indisputably indicate that the RyR Ca 2ϩ -release channel was the primary target for NO because other proteins involved in excitation-contraction coupling contain thiol groups as well. Therefore, experiments were repeated using the RyR agonist caffeine. Data from these latter experiments showed that two distinct NO donors reversibly decreased the amplitude of [Ca 2ϩ ] i transients. This indicates that the effects of NO on [Ca 2ϩ ] i transients are mediated by modification of thiols on the SR RyR Ca 2ϩ release channel. Data from the present study are in line with observations from previous studies that used isolated SR vesicles. Exposing SR vesicles to SNAP has been found to reduce the rate of caffeineinduced Ca 2ϩ release (18) . In addition, the open probability of the RyR Ca 2ϩ release channel in lipid bilayers is reduced after exposure to 100 M SNAP (18), which is a similar concentration to that used in the present study. Decreased open probability of the channel after exposure to NO may be the result of the inhibitory effect of NO on intersubunit cross-linking of thiol groups on the RyR channel, thereby preventing oxidant-induced activation of the channel (2). In contrast, at high concentration, SNAP increases RyR Ca ATPase activity. Although we could not definitely exclude this possibility, it is an unlikely explanation. Studies using SR vesicles indicated that NO donors did not affect (18) or even inhibit Ca 2ϩ reuptake (26) . Furthermore, in intact skeletal muscle fibers, Ca 2ϩ uptake was decreased because of treatment with NO donors (3) . In the present study, we studied the effects of NO donors only on the amplitude of [Ca 2ϩ ] i transients. Maximal amplitude is reached quickly after the initiation of the transient (Fig. 1) and is, therefore, primarily dependent on the rate of SR Ca 2ϩ release. In contrast, the height of the plateau after maximal amplitude is determined by the equilibrium between Ca 2ϩ release and reuptake in the SR and efflux from the myoplasm. Together, it is unlikely that the effects of NO donors on the amplitude of [Ca 2ϩ ] i transients arise from an increase in SR Ca 2ϩ ATPase activity. Baseline [Ca 2ϩ ] i levels were elevated after exposure to DEA-NO. This is in line with studies on intact mouse single fibers (3) and may be the result of inhibition of Ca 2ϩ ATPase activity (3, 26) or increased Ca 2ϩ leak from the SR (26) . It is tempting to speculate whether a direct relation exists between NO donor-induced eleva- (27) . However, in skinned skeletal muscle fibers, the apparent rate constant of caffeine-induced SR Ca 2ϩ efflux did not significantly change when the SR loading level was decreased to one-third of maximal loading (14) . Although studying the effects of NO donors on SR luminal Ca 2ϩ was beyond the scope of the present study, we do not believe that depletion of SR luminal Ca 2ϩ explains the NO donors mediated reduction in ACh and caffeine-induced [Ca 2ϩ ] i amplitudes. First, between subsequent stimulations, myotubes were incubated in HBSS containing 2.0 mM Ca 2ϩ for 10 min to refill SR. Second, studies on single RyR Ca 2ϩ release channels support a direct role for NO donors in decreasing the open probability of these channels (18) .
Our data are in apparent conflict with a recent report by Andrade et al. (3) , which found that exposing intact mouse skeletal muscle fibers to NO donors increases [Ca 2ϩ ] i during submaximal electrical stimulation. However, differences in experimental setup between the latter and the present study may partly explain these discrepancies. First, in their study, [Ca 2ϩ ] i responses were studied during submaximal activation, whereas we investigated the effects of NO on maximal [Ca 2ϩ ] i activation. Previous studies using an in situ skeletal muscle preparation indicated that the effects of NO depend on contraction pattern and frequency of stimulation (21) . SNAP did not affect twitch force at 0.5 Hz but decreased twitch force at 1.5 and 4.0 Hz. Also, SNAP decreased tetanic force at 40 Hz but did not affect tetanic force at 12 Hz (21). Likewise, NO differently affects SR Ca 2ϩ release in nonactivated and activated SR vesicles. In the former, NO donors increased Ca 2ϩ release (26) , whereas, in vesicles exposed to caffeine, NO donors decreased Ca 2ϩ release (18 ] i during submaximal activation in their study. Together, the picture emerges that NO has complex effects on [Ca 2ϩ ] i handling, acting on different steps in the excitation-contraction coupling cascade, and effects depend on concentration of NO and the extent of skeletal muscle activation.
In conclusion, Westerblad et al. (29) showed that [Ca 2ϩ ] i in mouse skeletal muscle fibers was reduced during low-frequency fatigue, which was probably the result of impaired SR Ca 2ϩ release. It has been shown that repetitive electrical stimulation of skeletal muscle at either 25 (12) or 100 Hz (4) enhances generation of NO. Our data indicate that NO impairs SR Ca 2ϩ release. Thus it could be speculated that reduced SR Ca 2ϩ release during low-frequency fatigue (partly) results from elevated generation of NO. However, further studies are needed to prove such a mechanism.
